We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
-2.75%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.5B
AUM Growth
-$124M
(-0.71%)
Cap. Flow
-$427M
Cap. Flow
% of AUM
-2.44%
Top 10 Holdings %
Top 10 Hldgs %
21.6%
Holding
1,393
New
110
Increased
432
Reduced
589
Closed
137
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TJX Companies
TJX
|
+$68.9M |
| 2 |
Applied Materials
AMAT
|
+$65.9M |
| 3 |
Netflix
NFLX
|
+$53.9M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$51.8M |
| 5 |
Ross Stores
ROST
|
+$50.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Synopsys
SNPS
|
+$72.2M |
| 2 |
CDW
CDW
|
+$64.9M |
| 3 |
Parker-Hannifin
PH
|
+$58.7M |
| 4 |
CTRA
Coterra Energy
CTRA
|
+$51.4M |
| 5 |
Genuine Parts
GPC
|
+$46.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.02% |
| 2 | Healthcare | 12.68% |
| 3 | Consumer Discretionary | 9.82% |
| 4 | Financials | 9.37% |
| 5 | Industrials | 7.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Neurocrine Biosciences
NBIX
$18.2B
| $340K | ﹤0.01% |
3,026
-6,238
| -67% | -$657K |
|
952
STMicroelectronics
STM
$43.1B
| $340K | ﹤0.01% |
7,886
+2,446
| +45% | +$117K |
|
953
Norwegian Cruise Line
NCLH
$9.53B
| $340K | ﹤0.01% |
20,628
-1,614
| -7% | -$29.8K |
|
|
CEQP
954
DELISTED
Crestwood Equity Partners LP
CEQP
| $339K | ﹤0.01% |
11,603
+2,338
| +25% | +$65.6K |
|
955
UGI
UGI
$7.87B
| $338K | ﹤0.01% |
14,711
-32,030
| -69% | -$795K |
|
956
Carlyle Group
CG
$16.1B
| $336K | ﹤0.01% |
+11,131
| New | +$359K |
|
957
RELX
RELX
$66.8B
| $336K | ﹤0.01% |
9,960
+1,696
| +21% | +$56K |
|
958
Fresenius Medical Care
FMS
$13.4B
| $333K | ﹤0.01% |
15,442
+443
| +3% | +$10.8K |
|
959
Globe Life
GL
$14B
| $332K | ﹤0.01% |
3,056
-185
| -6% | -$20.7K |
|
960
iShares MSCI USA Momentum Factor ETF
MTUM
$23.6B
| $332K | ﹤0.01% |
2,377
-2,366
| -50% | -$342K |
|
|
LTHM
961
DELISTED
Livent Corporation
LTHM
| $332K | ﹤0.01% |
18,032
-8,363
| -32% | -$191K |
|
962
Dick's Sporting Goods
DKS
$18.4B
| $330K | ﹤0.01% |
+3,040
| New | +$385K |
|
963
FirstEnergy
FE
$28.4B
| $329K | ﹤0.01% |
9,640
+2,370
| +33% | +$88.2K |
|
964
Transcat
TRNS
$760M
| $328K | ﹤0.01% |
3,350
-20
| -0.6% | -$1.91K |
|
965
Silicon Laboratories
SLAB
$7.14B
| $327K | ﹤0.01% |
2,824
-5,076
| -64% | -$701K |
|
966
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.72B
| $325K | ﹤0.01% |
9,552
+6,000
| +169% | +$222K |
|
967
FlexShares Global Upstream Natural Resources Index Fund
GUNR
$7.19B
| $324K | ﹤0.01% |
8,016
-19
| -0.2% | -$779 |
|
968
Ally Financial
ALLY
$13.1B
| $321K | ﹤0.01% |
12,022
-895
| -7% | -$25K |
|
969
Douglas Dynamics
PLOW
$992M
| $319K | ﹤0.01% |
10,582
+13
| +0.1% | +$398 |
|
970
Jones Lang LaSalle
JLL
$15.8B
| $318K | ﹤0.01% |
2,254
+569
| +34% | +$92.9K |
|
971
Global X Lithium & Battery Tech ETF
LIT
$1.46B
| $318K | ﹤0.01% |
5,757
-556
| -9% | -$34K |
|
972
Ares Management
ARES
$28.1B
| $316K | ﹤0.01% |
+3,075
| New | +$311K |
|
973
Cable One
CABO
$237M
| $315K | ﹤0.01% |
+512
| New | +$337K |
|
974
Littelfuse
LFUS
$10.4B
| $314K | ﹤0.01% |
1,271
+451
| +55% | +$122K |
|
975
Federal Realty Investment Trust
FRT
$10.9B
| $314K | ﹤0.01% |
+3,461
| New | +$341K |
|
Similar funds
EWA
MIC
P
OSAM
CB
EIM
SC
Glenmede Trust's Q3 2023 Portfolio in Review
As of Q3 2023, Glenmede Trust held 1,393 positions worth $17.5B, down 0.71% from $17.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Glenmede Trust's Q3 2023 filing shows 110 new, 432 increased, 589 reduced and 137 closed positions. Its largest new stake was Kenvue: 1,442,581 shares worth $29M. The largest sale was Synopsys, an estimated $72.2M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Glenmede Trust's largest Q3 2023 buy was Kenvue: 1,442,581 shares worth $29M.
- Glenmede Trust added most to TJX Companies in Q3 2023, an estimated $68.9M increase.
- Glenmede Trust's biggest Q3 2023 reduction was Synopsys, cutting an estimated $72.2M.
- Glenmede Trust fully exited Univar Solutions Inc. in Q3 2023, selling an estimated $21.6M.
- Glenmede Trust's ten largest holdings make up 22% of its $17.5B portfolio in Q3 2023.
- Glenmede Trust opened 110 new positions and closed 137 in Q3 2023.
- Glenmede Trust's portfolio value fell 0.71% quarter-over-quarter to $17.5B.
Based on Glenmede Trust's 13F filing for Q3 2023, filed 14 Nov 2023.